Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x100px
Organisation › Details

Inivata (Group)

Inivata is the liquid biopsy focused subsidiary of the NeoGenomics, Inc. (NASDAQ: NEO) Group. Inivata's InVision® liquid biopsy platform unlocks essential genomic information from a simple blood draw which may be used by clinicians to guide personalized cancer treatment, to monitor response to treatment and to detect relapse. The commercially available InVisionFirst®-Lung test offers highly sensitive testing and provides molecular insights that enable clinicians to make more informed treatment decisions for advanced NSCLC patients. Inivata's personalized RaDaR® assay allows the highly sensitive detection of residual disease and recurrence in certain cancers and has been granted Breakthrough Device Designation by the US FDA. Inivata is partnering with pharmaceutical, biotechnology companies and commercial entities in early through late-stage cancer development programs across a range of cancer types. The InVisionFirst®-Lung test and RaDaR are laboratory developed tests (LDTs) performed by Inivata's CLIA certified, CAP accredited laboratory in Research Triangle Park, North Carolina, USA. Inivata also has R&D laboratories in Cambridge, UK. Inivata's technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge. *

 

Period Start 2014-09-01 splitoff
Period End 2021-05-05 acquired
  Group NeoGenomics (Group)
  Today NeoGenomics (Group)
  Successor NeoGenomics (Group)
Product Industry  RaDaR™ minimal residual disease assay
Persons Person Stocum, Michael (Inivata 201603 CEO)
  Person 2 Rosenfeld, Nitzan (Inivata 201603 CSO)
     
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  Street The Portway Building
Granta Park
  City CB21 6GS Cambridge, Cambridgeshire
  Tel +44-1223-790880
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL.
     
   
Record changed: 2022-05-24

Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for NeoGenomics (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x300px




» top